Neurostar RTMS denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for neurostar rtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Requires Step Therapy Before NeuroStar TMS — and How to Appeal

UnitedHealthcare's coverage policy for NeuroStar TMS requires that patients document an adequate trial of one or more antidepressant medications — and in some cases psychotherapy — before TMS will be authorized. This "fail-first" or step-therapy requirement is the most common reason TMS prior authorizations are initially denied. The denial does not mean TMS is wrong for you; it means the submitted documentation did not satisfy UHC's prior-step requirements.

### Why This Denial Is Appealable

Step-therapy denials are overturned in a significant proportion of appeals when the patient has genuinely tried the required prior-step treatments and the chart documentation is complete and properly organized. Even if you have tried the required medications, the appeal may be necessary simply because the initial submission did not present that history in the format UHC's reviewers need. Many states also have step-therapy reform laws requiring commercial insurers to grant step-therapy exceptions when prior steps have been tried, were contraindicated, or are clinically inappropriate. Federal protections under ACA Section 2719 and ERISA Section 503 guarantee a full-and-fair internal review and independent external review if that fails.

### Your Appeal Timeline

• Peer-to-peer option: Before filing a formal appeal, ask your psychiatrist to request a peer-to-peer call with UHC's medical director. This is often the fastest path to resolving a step-therapy denial when the clinical history supports TMS.
• Internal appeal: File within the deadline on your denial letter. Pre-service appeals must be decided within 30 days.
• External review: If the internal appeal is adverse, you generally have four months to request independent external review. The external reviewer's decision is binding on UHC.
• Expedited option: Available within 72 hours for urgent clinical situations.

### Documentation to Gather

1. Prior-medication history — complete and dated — for each antidepressant (or other required step therapy) UHC's policy lists, provide the medication name, start date, stop date, dose range used (from chart records), and the documented clinical reason for stopping: inadequate response, intolerable side effects, or contraindication. This is the single most important document in a TMS step-therapy appeal. 2. Diagnosis and severity confirmation — current psychiatric evaluation notes, including a validated symptom-severity scale score, establishing the diagnosis and degree of illness. 3. Functional impairment documentation — records showing how treatment-resistant or inadequately treated depression affects your daily life, work, or safety. 4. Prescriber medical-necessity letter — a letter from your psychiatrist that specifically addresses each step-therapy requirement in UHC's TMS policy by name, confirms which prior steps were completed, and explains why TMS is now the appropriate next treatment.

### Criteria-Mapping Structure

Obtain UHC's current TMS prior-authorization and step-therapy criteria. Create a structured table with one row per required prior-step therapy listed in the policy. In each row: state the requirement verbatim; confirm whether it was completed, partially completed, or not completed (with clinical reason); cite the exact chart note, prescription record, or clinical entry that documents it; and attach that document as a labeled exhibit. For any step that was not completed due to a clinical reason (contraindication, allergy, prior adverse reaction), document that reason explicitly and attach supporting chart evidence. The applicable national psychiatric guideline organization (e.g., APA practice guidelines) may be cited to support TMS as an evidence-based option for patients with the documented treatment history.